Nucleus RadioPharma
United States
- Rochester, MN
- 18/10/2023
- Series A
- $56,000,000
Transforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise. Nucleus bridges the gap between innovation and clinic.
- Industry Pharmaceutical Manufacturing
- Website https://nucleusrad.com/
- LinkedIn https://www.linkedin.com/company/nucleus-radiopharma/about/
Related People
Charles ConroyFounder
United States -
Charlotte Metro
Contact: csconroyrph@gmail.com
Skilled negotiator and decision maker with excellent leadership, problem solving and relationship building skills. Expertise includes:
• Specialty Pharmacy
• Pharmacy Operations Management
• Business Development
• Product Development and Launch
• Alliance Management
• Strategic Planning
• Market Planning
• Corporate and Product Strategy
• Team Leadership and Development
• Acquisition Integration
• Operational Improvement
Specialties: Strategic Development, Pharmaceutical Marketing, Medical Device Marketing, Contract Negotiation, Nuclear Medicine, Process Management, New Business Start-up, Acquisitions, Mergers, Divestitures, Six Sigma, Sterile Compounding, Pharmaceutical Compounding, 340B, Supply Chain, Supply Chain Management
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)